KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Acquisitions (2016 - 2019)

Historic Acquisitions for Abbott Laboratories (ABT) over the last 11 years, with Q2 2019 value amounting to $82.0 million.

  • Abbott Laboratories' Acquisitions rose 35555.56% to $82.0 million in Q2 2019 from the same period last year, while for Jun 2019 it was $203.0 million, marking a year-over-year decrease of 9516.55%. This contributed to the annual value of $17.2 billion for FY2017, which is 2137875.0% up from last year.
  • According to the latest figures from Q2 2019, Abbott Laboratories' Acquisitions is $82.0 million, which was up 35555.56% from $78.0 million recorded in Q1 2019.
  • Over the past 5 years, Abbott Laboratories' Acquisitions peaked at $13.0 billion during Q1 2017, and registered a low of $7.0 million during Q4 2016.
  • Its 5-year average for Acquisitions is $2.0 billion, with a median of $78.0 million in 2019.
  • Its Acquisitions has fluctuated over the past 5 years, first skyrocketed by 5927142.86% in 2017, then tumbled by 9980.81% in 2018.
  • Abbott Laboratories' Acquisitions (Quarter) stood at $231.0 million in 2015, then tumbled by 96.97% to $7.0 million in 2016, then soared by 59271.43% to $4.2 billion in 2017, then crashed by 99.57% to $18.0 million in 2018, then skyrocketed by 355.56% to $82.0 million in 2019.
  • Its last three reported values are $82.0 million in Q2 2019, $78.0 million for Q1 2019, and $18.0 million during Q2 2018.